Gastrointestinal Drugs Market 2018; Leading Players Johnson & Johnson, Abbott Laboratories, Allergan, Takeda Pharmaceutical etc. - Detail Analysis and Forecasts To 2023

Market Research Future published a Cooked research report on “Asia Pacific Gastrointestinal Drugs Market Research Report - Forecast to 2023”– Market Analysis, Scope, Progress, Trends and Forecast to 2023.

Asia Pacific Gastrointestinal Drugs Market   - Overview

Gastrointestinal (GI) diseases affects stomach, large intestine and rectum, small intestine, esophagus, liver, gallbladder and pancreas. The symptoms of GI diseases are heartburn, indigestion, bloating, constipation and many more. According to a report by the World Gastroenterology Organization, 35-40 % of world’s total population is suffering from acute or chronic GI complication. Gastrointestinal diseases has gained a tremendous attention over the last few years.

Premium Sample Report Available @ https://www.marketresearchfuture.com/sample_request/633

The Asia gastrointestinal drugs market is expected to grow at a CAGR of 6.1% during the forecast period 2017-2023. According to a recent study report published by the Market Research Future, the Asia Pacific Gastrointestinal Drugs market is expected to gain eminence over the forecast period. The market is forecasted to demonstrate a steady growth by 2023, surpassing its previous growth records in terms of value with a constant CAGR during the anticipated period (2017–2023).

Asia Pacific Gastrointestinal Drugs Market - Scenario

Gastrointestinal (GI) diseases affects stomach, large intestine and rectum, small intestine, esophagus, liver, gallbladder, and pancreas. The diseases of gastrointestinal have become common in the people across world. According to Economic and Social Commission for Asia and the Pacific (ESCAP), in 2016, approximately 12.4% of the population in the region was over 60 years. According to Asian Development Bank, it was estimated that by 2050, 15% of total Malaysian population will be over 65 year old and in China, the elderly population will reach over 300 million by 2050. Thus, the increasing geriatric population in Asia likely to help the growth of the market over the forecast period.

The Asia gastrointestinal drugs market is expected to grow at a CAGR of 6.1% during the forecast period 2017-2023.

Asia Pacific Gastrointestinal Drugs Market - Key Players

AbbVie Inc. (US), AstraZeneca (UK), Johnson & Johnson (US), Valeant (US), Abbott Laboratories(US), Allergan Plc (US), Bayer AG (Germany), Janssen Biotech Inc. (US), Takeda Pharmaceutical Company Limited (Japan), Eisai Co., Ltd. (Japan), Valeant Pharmaceuticals (US), Sanofi (France), Janssen Biotech (US), GlaxoSmithKline Plc. (UK), Boehringer Ingelheim GmbH (Germany) and others are some of the prominent players at the forefront of competition in the Asia Pacific Gastrointestinal Drugs Market and are profiled in MRFR Analysis. 

Browse Complete Report @ https://www.marketresearchfuture.com/reports/asia-pacific-gastrointestinal-drugs-market-633

Asia Pacific Gastrointestinal Drugs Market - Segmentation

The Asia gastrointestinal drugs market is segmented on the basis of drug class and type of disease.

On the basis of drug class, it is segmented into acid neutralizers, laxatives & antidiarrheal, antiemetics, antiulcer, and others.

On the basis of type of disease, it is segmented into esophagus diseases, stomach diseases, intestinal diseases, rectum diseases, and others.

Asia Pacific Gastrointestinal Drugs Market - Key Findings

The Asia gastrointestinal drugs market is expected to reach USD 20,772.4 million by 2023 at a CAGR of 6.1%

Acid neutralizers segment accounted for the largest market share with 33.3% of the Asia gastrointestinal drug market, by drug types in 2016

In 2016, Esophagus diseases segment accounted for the major share of the market as it was the most widely occurring GI disease. The Asia esophagus diseases market by type of diseases is expected to reach USD 7,427.6 million by 2023, growing at a CAGR of 6.32% from 2017 to 2023

India is expected to be the fastest growing market at a CAGR of 6.60% during the forecast period 

Asia Pacific Gastrointestinal Drugs Market - Regional Analysis

Asia gastrointestinal drugs market is segmented on the basis of region: China, India, Republic of Korea, and Rest of Asia. Japan accounts for the major share of the market owning to the well-developed technology and high healthcare expenditure. People in this region are more focused on health, which drive the growth of the market. China is the second largest market, which is followed by India. Owing to the government support for the research & development, well-developed healthcare infrastructure, and high health care expenditure drive the China gastrointestinal drugs market. India is the fastest growing gastrointestinal drugs market across the region. Increasing need for the better treatment methods rapidly changing the healthcare sector. Additionally, the presence of huge opportunities for the development of the market have boosted the market growth.

Developing nations, for instance, India is experiencing high demand for gastrointestinal disorder drugs. Major pharmaceuticals drug manufacturers are using their technology and services to develop new drugs for gastrointestinal diseases to meet the growing demand. 

BRIEF TOC

1  Report Prologue

2   Introduction

2.1 Scope Of Study 14

2.2 Research Objective 14

2.3 Assumptions & Limitations 14

2.3.1 Assumptions 14

2.3.2 Limitations 14

2.4 Market Structure 15

3  Research Methodology

3.1 Primary Research 18

3.2 Secondary Research 18

3.3 Market Size Estimation 18

3.3.1 Market Share Analysis 19

3.4 Market Pricing Approach 20

4  Market Dynamics

4.1 Introduction 21

4.2 Drivers 22

4.2.1 Increasing Prevalence Of Gastrointestinal Diseases 22

4.2.2 Increasing Investments And Funding In The Field Of Life Science Research 22

4.2.3 Increasing Awareness Among The People 23

4.2.4 Growing Geriatric Population 23

Major TOC Continued…!

Get Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/633

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.